◆英語タイトル：Summit Therapeutics Plc (SUMM) - Financial and Strategic SWOT Analysis Review
Summit Therapeutics Plc (Summit), formerly Summit Corp Plc is a clinical-stage drug discovery and development company that offer therapies. The company conducts research and development on the treatment of rare diseases and infectious diseases including duchenne muscular dystrophy and the infectious disease caused by the bacteria C difficile. It develops ridinilazole, an antibiotic that has the potential to treat CDI and reduce disease recurrence. Summit undertakes utrophin modulation program for duchenne muscular dystrophy. The company also develops novel antibiotic program for the treatment of superbug C. difficile. It operates through other pharmaceutical companies and charity foundations and parent advocacy groups. The company operates through its office located in Cambridge, the US. Summit is headquartered in Abingdon, the UK.
Summit Therapeutics Plc Key Recent Developments
Dec 17,2018: Summit Therapeutics announces departure of Chief Financial Officer
Dec 11,2018: Summit Therapeutics reports financial results for the third quarter and nine months ended 31 October 2018 and operational progress
Nov 12,2018: Summit Highlights Importance of Innovation in Fight Against Antibiotic Resistance During Antibiotics Awareness Week
Oct 10,2018: Summit Therapeutics to participate in upcoming investor events
Oct 03,2018: Summit Highlights Phase 3-Ready Precision Antibiotic Ridinilazole at IDWeek 2018
This comprehensive SWOT profile of Summit Therapeutics Plc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Summit Therapeutics Plc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 – About the Company
Summit Therapeutics Plc – Key Information
Summit Therapeutics Plc – Overview
Summit Therapeutics Plc – Key Employees
Summit Therapeutics Plc – Key Employee Biographies
Summit Therapeutics Plc – Key Operational Heads
Summit Therapeutics Plc – Major Products and Services
Summit Therapeutics Plc – History
Summit Therapeutics Plc – Company Statement
Summit Therapeutics Plc – Locations And Subsidiaries
Summit Therapeutics Plc – Key Manufacturing facilities
Other Locations & Subsidiaries
Section 2 – Company Analysis
Summit Therapeutics Plc – Business Description
Summit Therapeutics Plc – Corporate Strategy
Summit Therapeutics Plc – SWOT Analysis
SWOT Analysis – Overview
Summit Therapeutics Plc – Strengths
Summit Therapeutics Plc – Weaknesses
Summit Therapeutics Plc – Opportunities
Summit Therapeutics Plc – Threats
Summit Therapeutics Plc – Key Competitors
Section 3 – Company Financial Performance Charts
Summit Therapeutics Plc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Appendix
Note*: Some sections may be missing if data is unavailable for the company
List of Tables
Summit Therapeutics Plc, Key Information
Summit Therapeutics Plc, Key Ratios
Summit Therapeutics Plc, Share Data
Summit Therapeutics Plc, Major Products and Services
Summit Therapeutics Plc, History
Summit Therapeutics Plc, Key Employees
Summit Therapeutics Plc, Key Employee Biographies
Summit Therapeutics Plc, Key Operational Heads
Summit Therapeutics Plc, Other Locations
Summit Therapeutics Plc, Subsidiaries
Summit Therapeutics Plc, Key Manufacturing facilities
Summit Therapeutics Plc, Key Competitors
Summit Therapeutics Plc, SWOT Analysis
Summit Therapeutics Plc, Ratios based on current share price
Summit Therapeutics Plc, Annual Ratios
Summit Therapeutics Plc, Interim Ratios
Capital Market Ratios
List of Figures
Summit Therapeutics Plc, Performance Chart
Summit Therapeutics Plc, Ratio Charts
| ★海外企業調査レポート[Summit Therapeutics Plc (SUMM)：企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら